Cramer Rosenthal McGlynn’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-133,319
Closed -$20.3M 109
2019
Q4
$20.3M Sell
133,319
-11,726
-8% -$1.72M 0.58% 73
2019
Q3
$21M Sell
145,045
-5,305
-4% -$793K 0.59% 65
2019
Q2
$22.4M Sell
150,350
-4,715
-3% -$630K 0.61% 67
2019
Q1
$19.9M Sell
155,065
-18,583
-11% -$2.19M 0.47% 80
2018
Q4
$18.6M Sell
173,648
-10,316
-6% -$1.15M 0.47% 77
2018
Q3
$21M Sell
183,964
-432,885
-70% -$49M 0.4% 89
2018
Q2
$64.8M Sell
616,849
-202,422
-25% -$20.4M 1.16% 31
2018
Q1
$76.5M Sell
819,271
-46,905
-5% -$4.26M 1.25% 20
2017
Q4
$75.8M Sell
866,176
-41,886
-5% -$3.74M 1.22% 21
2017
Q3
$80.3M Sell
908,062
-333,585
-27% -$28.3M 1.29% 19
2017
Q2
$101M Sell
1,241,647
-188,531
-13% -$14.3M 1.55% 8
2017
Q1
$99.3M Sell
1,430,178
-337,233
-19% -$23.3M 1.52% 7
2016
Q4
$119M Buy
1,767,411
+432,902
+32% +$29.4M 1.77% 3
2016
Q3
$97.6M Buy
1,334,509
+297,455
+29% +$21M 1.5% 5
2016
Q2
$71.3M Sell
1,037,054
-89,950
-8% -$6.3M 1.15% 15
2016
Q1
$80.1M Sell
1,127,004
-19,609
-2% -$1.33M 1.26% 10
2015
Q4
$86.4M Sell
1,146,613
-1,243,490
-52% -$89.8M 1.3% 9
2015
Q3
$155M Buy
2,390,103
+90,937
+4% +$6.01M 2.1% 3
2015
Q2
$148M Buy
2,299,166
+62,568
+3% +$4.22M 1.83% 4
2015
Q1
$157M Buy
2,236,598
+649,873
+41% +$42.9M 1.77% 3
2014
Q4
$103M Buy
1,586,725
+55,144
+4% +$3.41M 1.06% 28
2014
Q3
$82.6M Buy
1,531,581
+514,158
+51% +$27.9M 0.82% 39
2014
Q2
$54.4M Sell
1,017,423
-157,467
-13% -$8.11M 0.44% 90
2014
Q1
$56.1M Buy
1,174,890
+468
+0% +$21.9K 0.43% 91
2013
Q4
$56.4M Buy
1,174,422
+35,191
+3% +$1.61M 0.4% 88
2013
Q3
$48.9M Sell
1,139,231
-60,603
-5% -$2.63M 0.37% 97
2013
Q2
$51.4M Buy
+1,199,834
New +$51.6M 0.39% 91

Other funds holding STE

Cramer Rosenthal McGlynn's STE Position: Q1 2020 in Review

Cramer Rosenthal McGlynn sold out of Steris (STE) in Q1 2020, closing a stake of 133,319 shares — an estimated $20.3M sold.

Cramer Rosenthal McGlynn first reported a position in STE in Q2 2013 and held it in 27 quarters. The position peaked at $157M in Q1 2015. 553 funds tracked by Wall St. Rank hold STE as of Q1 2020.

  • Cramer Rosenthal McGlynn reported no remaining Steris position as of Q1 2020 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 133,319 Steris shares in Q1 2020, an estimated $20.3M.
  • Cramer Rosenthal McGlynn first reported a position in Steris in Q2 2013 and held it in 27 quarters.
  • Cramer Rosenthal McGlynn's Steris position peaked at $157M in Q1 2015.
  • 553 funds tracked by Wall St. Rank held Steris as of Q1 2020.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2020, filed 15 May 2020.